Search

Your search keyword '"van Broeckhoven C"' showing total 242 results

Search Constraints

Start Over You searched for: Author "van Broeckhoven C" Remove constraint Author: "van Broeckhoven C" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
242 results on '"van Broeckhoven C"'

Search Results

1. Protein network analysis reveals selectively vulnerable regions and biological processes in FTD

2. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8)

3. A novel Alzheimer disease locus located near the gene encoding tau protein

4. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimerʼs and Parkinsonʼs diseases

5. Using global team science to identify genetic parkinson's disease worldwide

6. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

7. Extensive genetic and phenotypic description of MAPT p.R406W in the Flanders-Belgian population

8. TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels

9. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

10. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

11. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

12. SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration

13. Correction to:A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

14. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

16. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study

17. Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

18. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

23. A novel Alzheimer disease locus located near the gene encoding tau protein

24. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A beta, tau, immunity and lipid processing (vol 51, pg 414, 2019)

25. Nat Genet

26. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

27. Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

28. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing

29. Using global team science to identify genetic Parkinson's disease worldwide

30. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia

31. Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitability

32. Using global team science to identify genetic parkinson's disease worldwide

33. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

34. CXCR4involvement in neurodegenerative diseases

35. Male-specific epistasis between WWC1 and TLN2 genes is associated with Alzheimer's disease

36. Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort

37. Meta-analysis of genetic association with diagnosed Alzheimer's disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing

38. Protein network analysis reveals selectively vulnerable regions and biological processes in FTD

40. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer’s and Parkinson’s diseases

41. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

42. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

43. Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies

44. Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

45. Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study

46. Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia

47. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases

48. Gene-based association studies report genetic links for clinical subtypes of frontotemporal dementia

49. Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease

50. Large-scale assessment of polyglutamine repeat expansions in Parkinson disease

Catalog

Books, media, physical & digital resources